Category: 2017 – 2

THE FRENCH APPROACH TO FIGHTING ANTIBIOTIC RESISTA...

Posted by admin | May 19, 2017 | 1, 2016, 2016 frontpage, Government engagement | 0

Register now

Posted by admin | May 19, 2017 | Uncategorized | 0

“Is that all?” Very little investment needed to sa...

Posted by admin | Sep 17, 2016 | Introduction | 0

Welcome

Posted by admin | Jul 11, 2016 | Introduction | 0

Introduction by Jean Carlet

Posted by admin | Apr 7, 2016 | Government engagement, Introduction | 0

2017

The Global Point Prevalence Survey – Biomérieux and Antwerp University Renew Their Commitment to Combat Antimicrobial Resistance

by admin | Jul 28, 2017 | Supporters 2017 | 0

Isabelle Caniaux, bioMérieux, France; Ann Versporten, Laboratory of Medical Microbiology, Vaccine...

Potential impact of telemonitoring by connected devices on the evaluation of antibiotic therapy’s duration in the ambulatory treatment of pulmonary infections

by admin | Aug 1, 2017 | 2017, Healthcare | 0
Drug-Resistant Tuberculosis: What Is The Situation, What Are The Needs To Roll It Back?

by admin | Jul 26, 2017 | 2017, Healthcare | 0
MedTech Europe

by admin | Sep 5, 2017 | Supporters 2017 | 0

Economics and Innovation

The Economics of reducing antibiotic use to reduce antimicrobial resistance

by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0

Dr Edward I Broughton Director of Research and Evaluation, Q&P Institute, USAID ASSIST URC, USA Human consumption of antibiotics is only beneficial to societal welfare when the correct antibiotics are used and they are given...

The role of the biomedical advanced research and development authority (BARDA) in promoting innovation in antibacterial product development

by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0
Socioeconomics, antimicrobial use and antimicrobial resistance

by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0
Containing antimicrobial resistance is a smart investment in global public health and wealth

by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0

2017

MedTech Europe

May 19, 2018

Institut Merieux

May 19, 2018

Less than one cent to save a patient fro...

Sep 21, 2017

A National Action Plan to Contain Antimi...

Sep 14, 2017

MedTech Europe

Sep 5, 2017

The Global Point Prevalence Survey ̵...

Jul 28, 2017

Because taking care is the essence of he...

Jul 28, 2017

Healthcare

Intensive care units as epicentres for antimicrobial resistance development

by admin | Jul 31, 2017 | 2017, Healthcare | 0

Dr Jean Carlet President, World Alliance Against Antibiotic Resistance and Professor Jan De Waele, Intensivist, Ghent University Hospital, Belgium Antimicrobial resistance (AMR) is rapidly increasing to a dangerous level...

Improving rational antibiotic treatment of common childhood conditions in Uganda

by admin | Jul 31, 2017 | 2017, Healthcare | 0
Infections in surgery – a key battleground to combat antimicrobial resistance

by admin | Aug 1, 2017 | 2017, Healthcare | 0
Potential impact of telemonitoring by connected devices on the evaluation of antibiotic therapy’s duration in the ambulatory treatment of pulmonary infections

by admin | Aug 1, 2017 | 2017, Healthcare | 0

Economics and Innovation

Socioeconomics, antimicrobial use and antimicrobial resistance

by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0

Molly Miller-Petrie Research Associate, CDDEP and Hellen Gelband, Associate Director for Policy, CDDEP Global patterns of health and disease vary by national economic status, and individual health and healthcare are also heavily...